Sign in
Active, not recruitingPhase 3

The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)

Key facts

Who runs it
Singapore National Eye Centre
Where
Singapore1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 3
People taking part
300 people enrolled
Started
21 Apr 2017
Ended
31 Dec 2025
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Atropine sulfate 0.01%
  • Placebo
Record updated
18 May 2025

Who can take part

Age
5 years to 9 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • One parent with myopia (<-3D in at least one eye)
  • SE +1.00D to -1.50D
  • Astigmatism < = 1.50D
  • Distance vision logMAR 0.2 or better in both eyes
  • Intraocular pressure of not greater than 21 mmHg
  • No allergy to atropine, cyclopentolate, proparacaine and benzalkonium chloride

Who cannot take part

  • Previous use of atropine or pirenzepine
  • Any eye or systemic disease that affect vision or refractive error
  • Conditions where topical atropine contraindicated
  • Known past/current amblyopia or strabismus

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Study of low dose atropine in preventing the onset and progression of myopia in high risk children with pre-myopia or low-myopia.

The 4 groups in the trial

  • Premyopia atropineExisting treatment, for comparison

    On Atropine 0.01%

    Treatment: Atropine sulfate 0.01%

  • Premyopia placeboPlacebo, for comparison

    On placebo

    Treatment: Placebo

  • Low myopia atropineExisting treatment, for comparison

    On Atropine 0.01% daily or every other day

    Treatment: Atropine sulfate 0.01%

  • Low myopia placeboPlacebo, for comparison

    On placebo

    Treatment: Placebo

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
18 May 2025